肥胖驱动的饥饿:从病理生理学到干预

Q2 Medicine Obesity Medicine Pub Date : 2025-03-01 Epub Date: 2025-02-05 DOI:10.1016/j.obmed.2025.100588
Ahmad Khusairi Azemi , Yahkub Babatunde Mutalub , Monsurat Abdulwahab , Aida Hanum Ghulam Rasool , Sagir Mustapha , Siti Qusyasyiah Ahmad Suhaimi , Siti Safiah Mokhtar
{"title":"肥胖驱动的饥饿:从病理生理学到干预","authors":"Ahmad Khusairi Azemi ,&nbsp;Yahkub Babatunde Mutalub ,&nbsp;Monsurat Abdulwahab ,&nbsp;Aida Hanum Ghulam Rasool ,&nbsp;Sagir Mustapha ,&nbsp;Siti Qusyasyiah Ahmad Suhaimi ,&nbsp;Siti Safiah Mokhtar","doi":"10.1016/j.obmed.2025.100588","DOIUrl":null,"url":null,"abstract":"<div><div>Obesity is a complex metabolic disorder driven by an imbalance between energy intake and expenditure. A critical pathogenetic component of obesity is dysregulated hunger and satiety mechanisms, driven by both central and peripheral factors. This review explores the pathophysiology of obesity-induced hunger, focusing on key mechanisms involving neurohormonal signals, gut-brain communication, and the dysregulation of appetite-related pathways. It discusses the roles of hormones such as ghrelin, leptin, and insulin, as well as the influence of inflammatory processes on hunger regulation. Additionally, environmental and psychological factors contributing to food cravings and reward-driven eating are considered. The article also examines current and emerging therapeutic interventions targeting hunger and appetite control, including pharmacologic treatments, such as glucagon-like peptide-1 (GLP-1) receptor agonists, lifestyle modifications, and bariatric surgery. Novel strategies under investigation, including appetite-regulating peptides, are highlighted. Bridging the understanding of the intricate mechanisms driving obesity-related hunger with therapeutic advances provides a comprehensive framework for more effective treatment strategies to combat obesity and its associated comorbidities which will ultimately improve patient outcomes.</div></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":"54 ","pages":"Article 100588"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Obesity-driven hunger: From pathophysiology to intervention\",\"authors\":\"Ahmad Khusairi Azemi ,&nbsp;Yahkub Babatunde Mutalub ,&nbsp;Monsurat Abdulwahab ,&nbsp;Aida Hanum Ghulam Rasool ,&nbsp;Sagir Mustapha ,&nbsp;Siti Qusyasyiah Ahmad Suhaimi ,&nbsp;Siti Safiah Mokhtar\",\"doi\":\"10.1016/j.obmed.2025.100588\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Obesity is a complex metabolic disorder driven by an imbalance between energy intake and expenditure. A critical pathogenetic component of obesity is dysregulated hunger and satiety mechanisms, driven by both central and peripheral factors. This review explores the pathophysiology of obesity-induced hunger, focusing on key mechanisms involving neurohormonal signals, gut-brain communication, and the dysregulation of appetite-related pathways. It discusses the roles of hormones such as ghrelin, leptin, and insulin, as well as the influence of inflammatory processes on hunger regulation. Additionally, environmental and psychological factors contributing to food cravings and reward-driven eating are considered. The article also examines current and emerging therapeutic interventions targeting hunger and appetite control, including pharmacologic treatments, such as glucagon-like peptide-1 (GLP-1) receptor agonists, lifestyle modifications, and bariatric surgery. Novel strategies under investigation, including appetite-regulating peptides, are highlighted. Bridging the understanding of the intricate mechanisms driving obesity-related hunger with therapeutic advances provides a comprehensive framework for more effective treatment strategies to combat obesity and its associated comorbidities which will ultimately improve patient outcomes.</div></div>\",\"PeriodicalId\":37876,\"journal\":{\"name\":\"Obesity Medicine\",\"volume\":\"54 \",\"pages\":\"Article 100588\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2451847625000089\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847625000089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

肥胖是一种复杂的代谢紊乱,由能量摄入和消耗之间的不平衡引起。肥胖的一个关键致病因素是由中枢和外周因素驱动的饥饿和饱腹机制失调。本文综述了肥胖诱导饥饿的病理生理学,重点探讨了涉及神经激素信号、肠-脑通讯和食欲相关通路失调的关键机制。它讨论了激素如胃饥饿素、瘦素和胰岛素的作用,以及炎症过程对饥饿调节的影响。此外,环境和心理因素有助于食物的渴望和奖励驱动饮食被考虑。本文还研究了当前和新兴的针对饥饿和食欲控制的治疗干预措施,包括药物治疗,如胰高血糖素样肽-1 (GLP-1)受体激动剂、生活方式改变和减肥手术。正在研究的新策略,包括食欲调节肽,被强调。将对肥胖相关饥饿的复杂机制的理解与治疗进展联系起来,为更有效的治疗策略提供了一个全面的框架,以对抗肥胖及其相关的合并症,最终将改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Obesity-driven hunger: From pathophysiology to intervention
Obesity is a complex metabolic disorder driven by an imbalance between energy intake and expenditure. A critical pathogenetic component of obesity is dysregulated hunger and satiety mechanisms, driven by both central and peripheral factors. This review explores the pathophysiology of obesity-induced hunger, focusing on key mechanisms involving neurohormonal signals, gut-brain communication, and the dysregulation of appetite-related pathways. It discusses the roles of hormones such as ghrelin, leptin, and insulin, as well as the influence of inflammatory processes on hunger regulation. Additionally, environmental and psychological factors contributing to food cravings and reward-driven eating are considered. The article also examines current and emerging therapeutic interventions targeting hunger and appetite control, including pharmacologic treatments, such as glucagon-like peptide-1 (GLP-1) receptor agonists, lifestyle modifications, and bariatric surgery. Novel strategies under investigation, including appetite-regulating peptides, are highlighted. Bridging the understanding of the intricate mechanisms driving obesity-related hunger with therapeutic advances provides a comprehensive framework for more effective treatment strategies to combat obesity and its associated comorbidities which will ultimately improve patient outcomes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Obesity Medicine
Obesity Medicine Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍: The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.
期刊最新文献
Asprosin and metabolic syndrome: Insulin resistance as a central mediating mechanism Beyond incretin therapy: integrating precision nutrition for sustained obesity management medications Adipocyte: A cutting-edge therapeutic target for obesity management Letter to editor: Evaluating the waist circumference and waist–to–height ratio as most reliable indicators to determine abdominal obesity among adolescents: Findings from a cross-sectional study in Kazakhstan Biomaterial-enables targeted drug delivery for obesity: Adipose-targeted nanocarriers and tissue-specific therapies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1